What’s in a Name: Out with Invizyne, In with eXoZymes

GEN - Genetic Engineering and Biotechnology News…

Factuality

Ownership

What’s in a Name: Out with Invizyne, In with eXoZymes

eXoZymes CEO Michael Heltzen Publicly traded Invizyne Technologies is renaming itself eXoZymes, a rebranding intended to raise the company’s profile by highlighting the sustainable, cell-free enzyme technology its co-founders and colleagues have spent more than a decade working to develop for uses that include active ingredients for nutraceuticals and biopharmaceuticals. eXoZymes replaces traditional chemical production methods with an approach …